The MEST score provides earlier risk prediction in lgA nephropathySean J. Barbour, Jan J. Weening, Andrew M. Herzenberg et al.|Kidney International|2015Cited by 297
Application of the International IgA Nephropathy Prediction Tool one or two years post-biopsySean J. Barbour, Fernanda Carvalho, Rosanna Coppo et al.|Kidney International|2022Cited by 82
Improving treatment decisions using personalized risk assessment from the International IgA Nephropathy Prediction ToolSean J. Barbour, Lucia Del Vecchio, Mark Canney et al.|Kidney International|2020Cited by 54